Onyx Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$8M
- Investors
-
4
Onyx General Information
Description
Developer of a biological research platform designed to model human immune responses to infections, inflammation, and medical treatments through longitudinal data collection and analysis. The company offers in-house laboratory processing, single-cell transcriptomics, immune receptor tracking, proteomics, metabolomics, genomics, and participant-level clinical data, enabling biopharmaceutical companies and artificial intelligence research teams to study complex biological processes, identify therapeutic targets, develop medicines, and select suitable participants for clinical trials.
Contact Information
Website
www.onyx.bioCorporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA
- United States
Corporate Office
- 626 Bancroft Way
- Suite A
- Berkeley, CA
- United States
Onyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 08-Oct-2026 | $8M | Completed | Generating Revenue |
Onyx Comparisons
Industry
Financing
Details
Onyx Competitors (18)
One of Onyx’s 18 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA |
Onyx Signals
Onyx Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dimension Capital Management | Corporation | Minority | ||
| Haystack Management Company | Venture Capital | Minority | ||
| Refactor Capital | Venture Capital | Minority | ||
| Standard Crypto | Venture Capital | Minority |
Onyx FAQs
-
When was Onyx founded?
Onyx was founded in 2024.
-
Where is Onyx headquartered?
Onyx is headquartered in Berkeley, CA.
-
What is the size of Onyx?
Onyx has 10 total employees.
-
What industry is Onyx in?
Onyx’s primary industry is Biotechnology.
-
Is Onyx a private or public company?
Onyx is a Private company.
-
What is Onyx’s current revenue?
The current revenue for Onyx is .
-
How much funding has Onyx raised over time?
Onyx has raised $8M.
-
Who are Onyx’s investors?
Dimension Capital Management, Haystack Management Company, Refactor Capital, and Standard Crypto have invested in Onyx.
-
Who are Onyx’s competitors?
Regenxbio, etherna, Adaptimmune Therapeutics, Intellia Therapeutics, and CytomX Therapeutics are some of the 18 competitors of Onyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process